3
Dec 2025
Breast density alerts may cause confusion and raise anxiety among women
New research by experts at the University of Sydney shows that breast density notification is leaving some women confused and anxious about their breast health.
Stay Informed!
3
Dec 2025
Sudden cardiac death risk is sharply elevated in people with diabetes
The risk of sudden cardiac death is higher both for people with type 1 and type 2 diabetes, according to a large study published in the European Heart Journal today (Thursday). The increase in risk is especially noticeable among younger adults.
3
Dec 2025
Retinal organoids provide a powerful tool to diagnose and study Leber congenital amaurosis
Leber Congenital Amaurosis (LCA) is an inherited retinal disease leading to severe vision impairment from early infancy, affecting 2-3 out of every 100,000 newborns. LCA is caused by variants in certain genes from which proteins essential for retinal cell function and survival are made.
3
Dec 2025
Poor kidney function associated with elevated Alzheimer’s markers in the blood
People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk of dementia, according to a study published December 3, 2025, in Neurology®, the medical journal of the American Academy of Neurology.
3
Dec 2025
New rapid test distinguishes real HIV infections from vaccine-related false positives
Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes.
3
Dec 2025
Experimental RNA drug shows promise for repairing DNA and healing tissue damage
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.
3
Dec 2025
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors-such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)-or glucagon-like peptide-1 (GLP-1) receptor agonists-such as semaglutide (Ozempic) and liraglutide (Victoza)-experience slower progression of frailty over one year compared with those starting other diabetes medications.
3
Dec 2025
Quicker access to Stop the Bleed program could have saved dozens of Maryland homicide victims
Quicker access to bleeding control interventions taught in the American College of Surgeons (ACS) Stop the Bleed program could have prevented the deaths of numerous homicide victims in Maryland, according to a first-of-its-kind analysis published in the Journal of the American College of Surgeons (JACS).
3
Dec 2025
NeuMap unveils the hidden architecture and life-long patterns of human neutrophils
Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage.
3
Dec 2025
Dark web users show markedly higher mental health vulnerabilities
The dark web – a hidden corner of the internet accessed through privacy-preserving tools like the Tor browser – operates beyond the reach of traditional search engines and public platforms.
